SG11201508642WA - Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones - Google Patents

Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Info

Publication number
SG11201508642WA
SG11201508642WA SG11201508642WA SG11201508642WA SG11201508642WA SG 11201508642W A SG11201508642W A SG 11201508642WA SG 11201508642W A SG11201508642W A SG 11201508642WA SG 11201508642W A SG11201508642W A SG 11201508642WA SG 11201508642W A SG11201508642W A SG 11201508642WA
Authority
SG
Singapore
Prior art keywords
expression
biologically active
elevated levels
synthesis system
active proteins
Prior art date
Application number
SG11201508642WA
Other languages
English (en)
Inventor
Alice Yam
Dan Groff
Patrick Rivers
Christopher D Thanos
Original Assignee
Sutro Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sutro Biopharma Inc filed Critical Sutro Biopharma Inc
Publication of SG11201508642WA publication Critical patent/SG11201508642WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201508642WA 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones SG11201508642WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361813914P 2013-04-19 2013-04-19
US201461937069P 2014-02-07 2014-02-07
PCT/US2014/034643 WO2014172631A2 (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using bacterial cells transformed to exhibit elevated levels of chaperone expression

Publications (1)

Publication Number Publication Date
SG11201508642WA true SG11201508642WA (en) 2015-11-27

Family

ID=50733442

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201508642WA SG11201508642WA (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones
SG10202108497TA SG10202108497TA (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10202108497TA SG10202108497TA (en) 2013-04-19 2014-04-18 Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Country Status (13)

Country Link
US (3) US10190145B2 (https=)
EP (1) EP2986731B1 (https=)
JP (2) JP6463732B2 (https=)
KR (1) KR102289258B1 (https=)
CN (1) CN105283556B (https=)
AU (1) AU2014253785B2 (https=)
CA (1) CA2909516C (https=)
DK (1) DK2986731T3 (https=)
ES (1) ES2922358T3 (https=)
HU (1) HUE059565T2 (https=)
IL (1) IL242148B (https=)
SG (2) SG11201508642WA (https=)
WO (1) WO2014172631A2 (https=)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201508642WA (en) * 2013-04-19 2015-11-27 Sutro Biopharma Inc Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones
US10316322B2 (en) * 2014-07-02 2019-06-11 Sutro Biopharma, Inc. High growth capacity auxotrophic Escherichia coli and methods of use
WO2016073791A1 (en) 2014-11-05 2016-05-12 Genentech, Inc. Methods of producing two chain proteins in bacteria
US10066002B2 (en) * 2014-11-05 2018-09-04 Genentech, Inc. Methods of producing two chain proteins in bacteria
US10487133B2 (en) 2014-12-19 2019-11-26 Sutro Biopharma, Inc. Codon optimization for titer and fidelity improvement
MX391051B (es) * 2014-12-30 2025-03-21 Celgene Corp Anticuerpos anti-cd47 y usos de los mismos.
HRP20192217T1 (hr) * 2015-03-06 2020-02-21 F. Hoffmann - La Roche Ag ULTRA-PROČIŠĆENI DsbA I DsbC TE POSTUPCI NJIHOVE IZRADE I UPORABE
US20170029798A1 (en) * 2015-07-27 2017-02-02 Cellivery Therapeutics, Inc. Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD)
KR20180048731A (ko) * 2015-08-20 2018-05-10 제넨테크, 인크. 재조합 폴리펩티드를 제조하기 위한 fkpa의 정제 및 그의 용도
CN105198983B (zh) * 2015-09-11 2018-11-06 中国石油大学(华东) 一种利于七次跨膜蛋白ccr5功能性表达的方法
CN106190940B (zh) * 2016-07-19 2019-06-14 北京三元基因药业股份有限公司 表达抗TNF抗体Fab片段的重组大肠杆菌工程菌
CN106399352B (zh) * 2016-11-09 2020-04-17 华东理工大学 调节目标蛋白表达的折叠因子及其应用
US11136586B2 (en) 2016-12-30 2021-10-05 Ntxbio, Llc Cell-free expression system having novel inorganic polyphosphate-based energy regeneration
CN110366428B (zh) 2016-12-30 2024-05-17 Vaxcyte公司 具有非天然氨基酸的多肽-抗原缀合物
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
US12227778B2 (en) 2016-12-30 2025-02-18 Nature's Toolbox, Inc. Cell-free expression system having novel inorganic polyphosphate-based energy regeneration
JP7325341B2 (ja) 2017-07-11 2023-08-14 シンソークス,インク. 非天然ヌクレオチドの組み込み及びその方法
EP3652318A1 (en) 2017-07-11 2020-05-20 Actym Therapeutics, Inc. Engineered immunostimulatory bacterial strains and uses thereof
KR20240141853A (ko) 2017-08-03 2024-09-27 신톡스, 인크. 자가면역 질환의 치료를 위한 사이토카인 접합체
JP2020533018A (ja) * 2017-08-11 2020-11-19 シンビトロバイオ, インコーポレイテッド 改善されたインビトロ転写/翻訳(txtl)システムおよびその使用
WO2019127469A1 (zh) * 2017-12-29 2019-07-04 康码(上海)生物科技有限公司 一种高效的能源再生体系(bes)、试剂盒及其制备方法
CN112004547A (zh) 2018-02-26 2020-11-27 新索思股份有限公司 Il-15缀合物及其用途
JP7340591B2 (ja) 2018-07-11 2023-09-07 アクティム・セラピューティクス・インコーポレイテッド 遺伝子操作された免疫刺激性細菌菌株およびその使用
EP3877407B1 (en) * 2018-11-05 2026-03-11 F. Hoffmann-La Roche AG Methods of producing two chain proteins in prokaryotic host cells
ES2944837T3 (es) * 2018-11-08 2023-06-26 Sutro Biopharma Inc Cepas de E. coli con citoplasma oxidativo
SG11202102930YA (en) 2018-11-08 2021-04-29 Synthorx Inc Interleukin 10 conjugates and uses thereof
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
EP3923974A4 (en) 2019-02-06 2023-02-08 Synthorx, Inc. IL-2 CONJUGATES AND METHODS OF USE THEREOF
US12024709B2 (en) 2019-02-27 2024-07-02 Actym Therapeutics, Inc. Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
WO2021178001A1 (en) * 2020-03-05 2021-09-10 Curie Co. Inc. Methods for cell free protein expression of mature polypeptides derived from zymogens and proproteins
CN114555128A (zh) 2019-08-15 2022-05-27 新索思股份有限公司 采用il-2缀合物的免疫肿瘤学组合疗法
US12234271B2 (en) 2019-09-10 2025-02-25 Synthorx, Inc. Il-2 conjugates and methods of use to treat autoimmune diseases
WO2021091986A1 (en) 2019-11-04 2021-05-14 Synthorx, Inc. Interleukin 10 conjugates and uses thereof
US20230032072A1 (en) * 2019-11-08 2023-02-02 Korea Institute Of Ocean Science & Technology Novel human epidermal growth factor-tf fusion protein and use thereof
CA3175683A1 (en) * 2020-04-29 2021-11-04 Xueyang FENG Compositions and methods for enhancing recombinant biosynthesis of cannabinoids
IL299074A (en) 2020-06-25 2023-02-01 Synthorx Inc Immuno-oncology therapeutic combination with IL-2 and anti-AGFR antibody conjugates
KR20220000028U (ko) 2020-06-29 2022-01-05 채인자 농작물용 농약 간편 분무장치
US20220089690A1 (en) * 2020-09-14 2022-03-24 Sutro Biopharma, Inc. Method for large scale production of antibodies using a cell-free protein synthesis system
IL301611A (en) 2020-10-09 2023-05-01 Synthorx Inc Immuno oncology combination therapy with il-2 conjugates and pembrolizumab
JP2023546010A (ja) 2020-10-09 2023-11-01 シンソークス, インコーポレイテッド Il-2コンジュゲートを用いた免疫腫瘍療法
TW202245843A (zh) 2021-02-12 2022-12-01 美商欣爍克斯公司 Il-2接合物及西米普利單抗(cemiplimab)之皮膚癌組合療法
WO2022174102A1 (en) 2021-02-12 2022-08-18 Synthorx, Inc. Lung cancer combination therapy with il-2 conjugates and an anti-pd-1 antibody or antigen-binding fragment thereof
EP4346904A1 (en) 2021-06-03 2024-04-10 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and cetuximab
EP4452327A1 (en) 2021-12-20 2024-10-30 Synthorx, Inc. Head and neck cancer combination therapy comprising an il-2 conjugate and pembrolizumab
WO2023122750A1 (en) 2021-12-23 2023-06-29 Synthorx, Inc. Cancer combination therapy with il-2 conjugates and cetuximab
CN116555061A (zh) * 2022-01-28 2023-08-08 北京师范大学 一种酿酒酵母突变体及其在制备酒精中的应用
US12163190B2 (en) * 2022-06-17 2024-12-10 Insitro, Inc. In situ sequencing of RNA transcripts with non-uniform 5 prime ends
CN115028691B (zh) * 2022-06-29 2024-09-10 青岛硕景生物科技有限公司 一种检测试纸用的独立质控系统、杂交瘤细胞株、质控线用包被单克隆抗体及其应用
WO2024136899A1 (en) 2022-12-21 2024-06-27 Synthorx, Inc. Cancer therapy with il-2 conjugates and chimeric antigen receptor therapies
CN121263208A (zh) 2023-03-20 2026-01-02 新索思股份有限公司 使用il-2 peg缀合物的癌症疗法
CN116925196B (zh) * 2023-06-08 2025-04-18 齐鲁工业大学(山东省科学院) 小分子热休克蛋白rsp_1572在提高宿主菌环境耐受性中的应用
WO2025158385A1 (en) 2024-01-25 2025-07-31 Genzyme Corporation Pegylated il-2 for suppressing adaptive immune response to gene therapy
CN118048325B (zh) * 2024-04-16 2024-07-16 天津凯莱英生物科技有限公司 酶的高通量筛选方法及酶库的构建方法
WO2025218039A1 (zh) * 2024-04-16 2025-10-23 天津凯莱英生物科技有限公司 酶的高通量筛选方法及酶库的构建方法
WO2025240255A1 (en) * 2024-05-11 2025-11-20 Biodiscovery, Llc Systems and methods of cell-free protein expression

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10145694A1 (de) * 2001-09-17 2003-04-03 Roche Diagnostics Gmbh Verfahren zur Erhöhung der Löslichkeit, der Expressionsrate und der Aktivität von Proteinen während der rekombinanten Herstellung
US20060134739A1 (en) * 2003-03-11 2006-06-22 Chatterjee Deb K Synthesis of proteins by cell-free protein expression
JP2005253432A (ja) * 2004-03-15 2005-09-22 Sekisui Chem Co Ltd タンパク質の生産方法、並びにそれに使用するための組成物、試薬及びキット
JP4561243B2 (ja) * 2004-08-27 2010-10-13 株式会社豊田中央研究所 無細胞タンパク質合成系のための媒体
WO2008066583A2 (en) * 2006-06-29 2008-06-05 The Board Of Trustees Of The Leland Stanford Junior University Cell-free synthesis of proteins containing unnatural amino acids
CA2673765A1 (en) * 2007-01-18 2008-07-24 The Board Of Trustees Of The Leland Stanford Junior University Enhanced cell-free synthesis of active proteins containing disulfide bonds
JP5798489B2 (ja) * 2009-01-12 2015-10-21 ストロ バイオファーマ, インコーポレイテッド インビトロタンパク質合成システムを用いて非天然アミノ酸をタンパク質に選択的に導入するためのモノチャージシステム
US20110136169A1 (en) * 2009-11-20 2011-06-09 Rutgers, The State University Of New Jersey Expression system compositions and methods
CN102732548A (zh) * 2012-05-16 2012-10-17 中国农业大学 一种表达蛇毒激肽原酶的高效麦胚无细胞蛋白合成系统的建立及应用
PL2906592T3 (pl) * 2012-10-12 2019-07-31 Sutro Biopharma, Inc. Proteolityczna inaktywacja wybranych białek w ekstraktach bakteryjnych dla ulepszonej ekspresji
SG11201508642WA (en) 2013-04-19 2015-11-27 Sutro Biopharma Inc Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones

Also Published As

Publication number Publication date
ES2922358T3 (es) 2022-09-13
EP2986731A2 (en) 2016-02-24
SG10202108497TA (en) 2021-09-29
JP6463732B2 (ja) 2019-02-06
IL242148B (en) 2019-03-31
AU2014253785B2 (en) 2018-07-19
HK1220993A1 (en) 2017-05-19
US20210054429A1 (en) 2021-02-25
CN105283556A (zh) 2016-01-27
DK2986731T3 (da) 2022-08-01
JP2016518833A (ja) 2016-06-30
US20190161781A1 (en) 2019-05-30
US20140315245A1 (en) 2014-10-23
US10190145B2 (en) 2019-01-29
KR20160002913A (ko) 2016-01-08
CA2909516C (en) 2023-03-07
JP2018157837A (ja) 2018-10-11
WO2014172631A4 (en) 2015-02-19
HUE059565T2 (hu) 2022-11-28
WO2014172631A2 (en) 2014-10-23
WO2014172631A3 (en) 2014-12-18
CN105283556B (zh) 2020-07-14
CA2909516A1 (en) 2014-10-23
EP2986731B1 (en) 2022-05-18
KR102289258B1 (ko) 2021-08-11
AU2014253785A1 (en) 2015-11-05
US10774354B2 (en) 2020-09-15

Similar Documents

Publication Publication Date Title
IL242148B (en) Expression of biologically active proteins in a cell-free bacterial expression system containing high levels of external chaperones
IL273504A (en) Compositions for cell culture with antioxidants and methods for polypeptide production
IL237530A0 (en) Gene and protein expression characteristics of adherent stromal cells grown in 3D
SG10201608341XA (en) Cd40l expressing mammalian cells and their use
EP2710578A4 (en) SYSTEMS AND METHOD FOR DISPLAY SYSTEMS WITH DYNAMIC POWER CONTROL
HRP20190484T1 (hr) Pripravci stanične kulture i postupci proizvodnje polipeptida
EP2895594A4 (en) ELECTROSYNTHETIC MICROBIAL CELLS
GB201100180D0 (en) Tumour cell and tissue culture
ZA201409367B (en) A method to produce a medicinal product comprising a biologically active protein and the resulting product
IL240339A0 (en) An algal cell with impaired chlorophyll with enhanced growth and production
EP2753346A4 (en) CERAMIDASE AND CELL DIFFERENTIATION
EP3072953A4 (en) Cell culture container and container in which cell culture has been accommodated
SG11201507828VA (en) Method for culturing hepatoblast-like cells and culture product thereof
EP3037516A4 (en) Liquid delivery device and cell culture device using same
IL224813B (en) Compositions comprising th1 killer cells and uses thereof
CA144251S (en) Sofa
PL2861713T3 (pl) Sposób hodowli komórkowej i system
EP3068875A4 (en) Post-natal hematopoeitic endothelial cells and their isolation and use
EP2964746A4 (en) FERMENTATION MONITORING DEVICE FOR FUEL CELL
EP2912164A4 (en) MICRO-RNAS AND CELL PROGRAMMING
PT2753346T (pt) Ceramidase e diferenciação celular
EP3075846A4 (en) Cell culture medium and culture method using same
PL3008165T3 (pl) Kontrola konduktywności w fermentacji beztlenowej
EP3042949A4 (en) Cultivation method for bacteria belonging to genus collimonas and storage method
GB201218268D0 (en) Cell growth and differentation